ClinicalTrials.Veeva

Menu
T

Trials365, LLC. | Shreveport, LA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Platinum
Trastuzumab
INCB123667
Bevacizumab
TIVDAK
ACR-368

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 11 total trials

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

This is an open label Phase 2 study to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitiza...

Enrolling
Endometrial Adenocarcinoma
Drug: ACR-368
Diagnostic Test: OncoSignature
Locations recently updated

This study will evaluate the safety and efficacy of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer (PROC) With Cyclin E1 Overexpre...

Enrolling
Ovarian Cancer
Drug: INCB123667

TIVDAK is used for the treatment of cervical cancer that has come back after chemotherapy. Chemotherapy is a treatment that uses medicines to stop th...

Enrolling
Cervical Cancer
Drug: TIVDAK

The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial carcinom...

Active, not recruiting
Endometrial Cancer
Drug: Matching Placebo for selinexor
Drug: Selinexor

This study is designed to assess efficacy and safety of T-DXd adjuvant therapy, with or without radiotherapy, post-surgery in anticancer treatment na...

Enrolling
Endometrial Cancer
Drug: Trastuzumab Deruxtecan
Drug: Chemotherapy

This clinical trial is designed to evaluate the efficacy and safety of T-DXd in combination with bevacizumab versus bevacizumab monotherapy as first-...

Enrolling
Ovarian Cancer
Drug: Trastuzumab Deruxtecan
Drug: Bevacizumab

The purpose of this study is to compare how well Rina-S (GEN1184) works compared to treatment of physician's choice (paclitaxel or doxorubicin) that...

Enrolling
Endometrial Cancer
Recurrent or Progressive Endometrial Cancer
Drug: Rina-S
Drug: IC

This phase 3 study will be conducted in different countries all over the world.The purpose of this study is to compare how well Rina-S works against...

Active, not recruiting
Platinum-resistant Ovarian Cancer
Drug: Topotecan
Drug: Gemcitabine
Locations recently updated

The purpose of this study is to evaluate INCB123667 versus investigator's choice of chemotherapy in participants with platinum-resistant ovarian canc...

Enrolling
Ovarian Cancer
Drug: INCB123667
Drug: Investigator's choice of chemotherapy

The purpose of the study is to identify the optimal dose level of NP-G2-044 in combination with standard of care (SOC) pegylated liposomal doxorubici...

Active, not recruiting
Platinum-resistant Ovarian Cancer
Drug: NP-G2-044
Drug: PLD

Trial sponsors

Daiichi Sankyo logo
Genmab logo
Incyte logo
A
I
Karyopharm Therapeutics logo
N
Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems